Alcorn Harry W Jr
- SEC CIK
- 0001186761
No open-market purchases or sales filed in the past year.
Current role at each company
- DMAC DiaMedica Therapeutics Inc.SVP, Clinical Operationsas of Sep 15, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Alcorn Harry W Jr as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2021 (view filing) | Sep 15 | Same day | Alcorn Harry W JrSVP, Clinical Operations | PPurchaseVoting Common Shares, no par value per share | +15.0K | $3.80 | +$57.0K | +52.5%43.6K after | |
| Aug 16, 2021 (view filing) | Aug 16 | Same day | Alcorn Harry W JrSenior VP, Clinical Operations | PPurchaseVoting Common Shares, no par value per share | +20.3K | $3.09 | +$62.8K | +246.0%28.6K after | 2 lots |
| Aug 16, 2021 (view filing) | Aug 16 | Same day | Alcorn Harry W JrSenior VP, Clinical Operations | PPurchaseVoting Common Shares, no par value per share | +399 | $3.07 | +$1.22K | New position399 after |